Jpmorgan Chase & CO Ligand Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 56,451 shares of LGND stock, worth $6.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,451
Previous 63,772 11.48%
Holding current value
$6.5 Million
Previous $5.37 Million 5.23%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$82.7 - $110.11 $605,446 - $806,115
-7,321 Reduced 11.48%
56,451 $5.65 Million
Q3 2024

Nov 08, 2024
SELL
$82.7 - $110.11 $605,446 - $806,115
-7,321 Reduced 11.48%
56,451 $5.65 Million
Q2 2024

Dec 26, 2024
BUY
$68.53 - $87.91 $501,708 - $643,589
7,321 Added 12.97%
63,772 $5.37 Million
Q2 2024

Aug 12, 2024
BUY
$68.53 - $87.91 $943,383 - $1.21 Million
13,766 Added 27.53%
63,772 $5.37 Million
Q1 2024

Dec 26, 2024
SELL
$68.64 - $89.2 $442,384 - $574,894
-6,445 Reduced 11.42%
50,006 $3.66 Million
Q1 2024

May 10, 2024
SELL
$68.64 - $89.2 $883,602 - $1.15 Million
-12,873 Reduced 20.47%
50,006 $3.66 Million
Q4 2023

Dec 26, 2024
BUY
$49.57 - $72.63 $318,635 - $466,865
6,428 Added 11.39%
62,879 $4.49 Million
Q4 2023

Feb 12, 2024
BUY
$49.57 - $72.63 $132,054 - $193,486
2,664 Added 4.42%
62,879 $4.49 Million
Q3 2023

Nov 14, 2023
BUY
$58.86 - $72.67 $1.44 Million - $1.78 Million
24,481 Added 68.51%
60,215 $3.61 Million
Q2 2023

Aug 11, 2023
SELL
$69.53 - $79.33 $859,043 - $980,122
-12,355 Reduced 25.69%
35,734 $2.58 Million
Q1 2023

May 18, 2023
BUY
$65.67 - $77.08 $1.28 Million - $1.5 Million
19,445 Added 67.89%
48,089 $3.54 Million
Q1 2023

May 11, 2023
SELL
$65.67 - $77.08 $669,111 - $785,368
-10,189 Reduced 26.24%
28,644 $2.11 Million
Q4 2022

Feb 13, 2023
SELL
$61.72 - $96.74 $78,507 - $123,053
-1,272 Reduced 3.17%
38,833 $2.59 Million
Q3 2022

Nov 14, 2022
BUY
$0.01 - $107.56 $5 - $59,803
556 Added 1.41%
40,105 $3.45 Million
Q2 2022

Aug 11, 2022
SELL
$74.52 - $117.06 $149,710 - $235,173
-2,009 Reduced 4.83%
39,549 $3.53 Million
Q1 2022

May 11, 2022
BUY
$94.99 - $151.56 $155,308 - $247,800
1,635 Added 4.1%
41,558 $4.68 Million
Q4 2021

Feb 10, 2022
SELL
$127.69 - $165.85 $18,515 - $24,048
-145 Reduced 0.36%
39,923 $6.17 Million
Q3 2021

Nov 12, 2021
BUY
$102.33 - $144.73 $4.1 Million - $5.8 Million
40,068 New
40,068 $5.58 Million

Others Institutions Holding LGND

# of Institutions
262
Shares Held
18M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email